Olav Engebråten

Associate Professor - Institute for Cancer Research
Image of Olav Engebråten
Norwegian version of this page
Username
Visiting address Ullernchausseen 70 OUS Radiumhospitalet 0372 Oslo
Postal address Postboks 4950 Nydalen OUS, Rikshospitalet 0424 Oslo

Publications

  • Morra, Anna; Schreurs, Maartje A. C.; Andrulis, Irene L.; Anton-Culver, Hoda; Augustinsson, Annelie & Beckmann, Matthias W. [Show all 125 contributors for this article] (2023). Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival. Cancer Medicine. ISSN 2045-7634. 12(15), p. 16142–16162. doi: 10.1002/cam4.6272. Full text in Research Archive
  • Mo, Torgeir; Brandal, Siri Helene Bertelsen; Geier, Oliver; Engebråten, Olav; Nilsen, Line & Kristensen, Vessela N. [Show all 10 contributors for this article] (2023). MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients. Cancers. ISSN 2072-6694. 15(18). doi: 10.3390/cancers15184662. Full text in Research Archive
  • Levi, Hagai; Carmi, Shai; Rosset, Saharon; Yerushalmi, Rinat; Zick, Aviad & Yablonski-Peretz, Tamar [Show all 155 contributors for this article] (2023). Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. Journal of Medical Genetics. ISSN 0022-2593. 60(12), p. 1186–1197. doi: 10.1136/jmg-2023-109185.
  • Figlioli, Gisella; Billaud, Amandine; Wang, Qin; Bolla, Manjeet K.; Dennis, Joe & Lush, Michael [Show all 96 contributors for this article] (2023). Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases. Cancers. ISSN 2072-6694. 15(13). doi: 10.3390/cancers15133313.
  • Haugen, Mads; von der Lippe Gythfeldt, Hedda; Egeland, Eivind Valen; Normann, Lisa Svartdal; Pandya, Abhilash D. & Vedin, Lise-Lotte [Show all 15 contributors for this article] (2023). Liver X receptors induce antiproliferative effects in basal-like breast cancer. Molecular Oncology. ISSN 1574-7891. doi: 10.1002/1878-0261.13476. Full text in Research Archive
  • Figlioli, Gisella; Billaud, Amandine; Ahearn, Thomas U.; Antonenkova, Natalia N.; Becher, Heiko & Beckmann, Matthias W. [Show all 114 contributors for this article] (2023). FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women. European Journal of Human Genetics. ISSN 1018-4813. 31(5), p. 578–587. doi: 10.1038/s41431-022-01257-w.
  • Pettersen, Solveig; Øy, Geir Frode; Egeland, Eivind Valen; Juell, Siri; Engebråten, Olav & Mælandsmo, Gunhild Mari [Show all 7 contributors for this article] (2023). Breast cancer patient-derived explant cultures recapitulate in vivo drug responses. Frontiers in Oncology. ISSN 2234-943X. 13. doi: 10.3389/fonc.2023.1040665. Full text in Research Archive
  • Morra, Anna; Mavaddat, Nasim; Muranen, Taru A.; Ahearn, Thomas U.; Allen, Jamie & Andrulis, Irene L. [Show all 84 contributors for this article] (2023). The impact of coding germline variants on contralateral breast cancer risk and survival. American Journal of Human Genetics. ISSN 0002-9297. 110(3), p. 475–486. doi: 10.1016/j.ajhg.2023.02.003. Full text in Research Archive
  • Svartdal, Lisa Gregusson; Haugen, Mads; Hongisto, Vesa; Aure, Miriam Ragle; Leivonen, Suvi-Katri & Kristensen, Vessela N. [Show all 10 contributors for this article] (2023). High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer. PLOS ONE. ISSN 1932-6203. 18(1). doi: 10.1371/journal.pone.0280507. Full text in Research Archive
  • Mueller, Stefanie H.; Lai, Alvina G.; Valkovskaya, Maria; Michailidou, Kyriaki; Bolla, Manjeet K. & Wang, Qin [Show all 207 contributors for this article] (2023). Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry. Genome Medicine. ISSN 1756-994X. 15(7). doi: 10.1186/s13073-022-01152-5. Full text in Research Archive
  • Dixon-Suen, Suzanne C.; Lewis, Sarah; Martin, Richard M.; English, Dallas R.; Boyle, Terry & Giles, Graham G. [Show all 174 contributors for this article] (2022). Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study. British Journal of Sports Medicine. ISSN 0306-3674. 56(20), p. 1157–1170. doi: 10.1136/bjsports-2021-105132.
  • Dorling, Leila; Carvalho, Sara; Allen, Jamie; Parsons, Michael T.; Fortuno, Cristina & Kristensen, Vessela N. [Show all 50 contributors for this article] (2022). Breast cancer risks associated with missense variants in breast cancer susceptibility genes. Genome Medicine. ISSN 1756-994X. 14(1), p. 1–17. doi: 10.1186/s13073-022-01052-8. Full text in Research Archive
  • Bjørklund, Sunniva; Aure, Miriam Ragle; Häkkinen, Jari; Vallon-Christersson, Johan; Kumar, Surendra & Bull Evensen, Katrine [Show all 34 contributors for this article] (2022). Subtype and cell type specific expression of lncRNAs provide insight into breast cancer. Communications Biology. ISSN 2399-3642. 5(1), p. 1–14. doi: 10.1038/s42003-022-03559-7. Full text in Research Archive
  • Mo, Torgeir; Brandal, Siri Helene Bertelsen; Kohn Luque, Alvaro; Engebråten, Olav; Kristensen, Vessela N. & Fleischer, Thomas [Show all 8 contributors for this article] (2022). Quantification of Tumor Hypoxia through Unsupervised Modelling of Consumption and Supply Hypoxia MR Imaging in Breast Cancer. Cancers. ISSN 2072-6694. 14(5), p. 1–16. doi: 10.3390/cancers14051326. Full text in Research Archive
  • Dennis, Joe; Tyrer, Jonathan P.; Walker, Logan C.; Michailidou, Kyriaki; Dorling, Leila & Kristensen, Vessela N. [Show all 50 contributors for this article] (2022). Rare germline copy number variants (CNVs) and breast cancer risk. Communications Biology. ISSN 2399-3642. 5, p. 1–15. doi: 10.1038/s42003-021-02990-6. Full text in Research Archive
  • Ahearn, Thomas U.; Zhang, Haoyu; Michailidou, Kyriaki; Milne, Roger L.; Bolla, Manjeet K. & Dennis, Joe [Show all 205 contributors for this article] (2022). Common variants in breast cancer risk loci predispose to distinct tumor subtypes. Breast Cancer Research. ISSN 1465-5411. 24(1), p. 1–13. doi: 10.1186/s13058-021-01484-x. Full text in Research Archive
  • Park, Hanla A.; Neumeyer, Sonja; Michailidou, Kyriaki; Bolla, Manjeet K.; Wang, Qin & Kristensen, Vessela N. [Show all 50 contributors for this article] (2021). Mendelian randomisation study of smoking exposure in relation to breast cancer risk. British Journal of Cancer. ISSN 0007-0920. 125(8), p. 1135–1145. doi: 10.1038/s41416-021-01432-8. Full text in Research Archive
  • Johnson, Nichola; Maguire, Sarah; Morra, Anna; Kapoor, Pooja Middha; Tomczyk, Katarzyna & Kristensen, Vessela N. [Show all 50 contributors for this article] (2021). CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. British Journal of Cancer. ISSN 0007-0920. 124, p. 842–854. doi: 10.1038/s41416-020-01185-w. Full text in Research Archive
  • Rye, Inga Hansine; Huse, Kanutte; Josefsson, Sarah Elisabet; Kildal, Wanja; Danielsen, Håvard Emil Greger & Schlichting, Ellen [Show all 28 contributors for this article] (2021). Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression. Molecular Oncology. ISSN 1574-7891. 16(1), p. 88–103. doi: 10.1002/1878-0261.13047. Full text in Research Archive
  • Morra, Anna; Escala-Garcia, Maria; Beesley, Jonathan; Keeman, Renske; Canisius, Sander & Ahearn, Thomas U. [Show all 50 contributors for this article] (2021). Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. Breast Cancer Research. ISSN 1465-5411. 23:86(1), p. 1–18. doi: 10.1186/s13058-021-01450-7. Full text in Research Archive
  • Haugen, Mads Haugland; Lingjærde, Ole Christian; Hedenfalk, Ingrid; Garred, Øystein; Borgen, Elin & Loman, Niklas [Show all 12 contributors for this article] (2021). Protein signature predicts response to neoadjuvant treatment with chemotherapy and bevacizumab in HER2-negative breast cancers. JCO Precision Oncology (JCO PO). 5, p. 286–306. doi: 10.1200/PO.20.00086. Full text in Research Archive
  • Park, JooYong; Choi, Ji-Yeob; Choi, Jaesung; Chung, Seokang; Song, Nan & Park, Sue K [Show all 50 contributors for this article] (2021). Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies? Cancers. ISSN 2072-6694. 13:2370(10), p. 1–21. doi: 10.3390/cancers13102370. Full text in Research Archive
  • Engebraaten, Olav; Yau, Christina; Berg, Kristian; Borgen, Elin; Garred, Øystein & Berstad, Maria Elisabeth Brandal [Show all 11 contributors for this article] (2021). RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer. Nature Communications. ISSN 2041-1723. 12(1). doi: 10.1038/s41467-021-26018-z. Full text in Research Archive
  • Erdelyi, Katalin; Ditroi, Tamas; Johansson, Henrik J.; Czikora, Agnes; Balog, Noemi & Silwal-Pandit, Laxmi [Show all 19 contributors for this article] (2021). Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation. Proceedings of the National Academy of Sciences of the United States of America. ISSN 0027-8424. 118(45). doi: 10.1073/pnas.2100050118. Full text in Research Archive
  • Krüger, Kristi; Silwal-Pandit, Laxmi; Wik, Elisabeth; Straume, Oddbjørn; Stefansson, Ingunn Marie & Borgen, Elin [Show all 10 contributors for this article] (2021). Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer. Scientific Reports. ISSN 2045-2322. 11, p. 1–11. doi: 10.1038/s41598-021-81914-0. Full text in Research Archive
  • Pandya, Abhilash D.; Iversen, Tore Geir; Moestue, Siver Andreas; Grinde, Maria Tunset; Mørch, Ýrr Asbjørg & Snipstad, Sofie [Show all 13 contributors for this article] (2021). Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft. Nanomaterials. ISSN 2079-4991. 11(5). doi: 10.3390/nano11051140. Full text in Research Archive
  • Barkovskaya, Anna; Goodwin, Craig; Seip, Kotryna; Hilmarsdòttir, Bylgja; Pettersen, Solveig & Stalnecker, Clint [Show all 13 contributors for this article] (2021). Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen. Molecular Oncology. ISSN 1574-7891. 15(8), p. 2026–2045. doi: 10.1002/1878-0261.12951. Full text in Research Archive
  • Liu, Jingjing; van der Smissen, Wendy J. C. Prager; Collee, Margriet J.; Bolla, Manjeet K.; Wang, Qin & Kristensen, Vessela N. [Show all 82 contributors for this article] (2020). Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk. Scientific Reports. ISSN 2045-2322. 10:9688(1), p. 1–14. doi: 10.1038/s41598-020-65665-y. Full text in Research Archive
  • Kramer, Iris; Hooning, Maartje J.; Mavaddat, Nasim; Hauptmann, Michael; Keeman, Renske & Steyerberg, Ewout W. [Show all 54 contributors for this article] (2020). Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. American Journal of Human Genetics. ISSN 0002-9297. 107(5), p. 837–848. doi: 10.1016/j.ajhg.2020.09.001.
  • Pladsen, Arne Valebjørg; Nilsen, Gro; Rueda, Oscar M.; Aure, Miriam Ragle; Borgan, Ørnulf & Liestøl, Knut [Show all 18 contributors for this article] (2020). DNA copy number motifs are strong and independent predictors of survival in breast cancer. Communications Biology. ISSN 2399-3642. 3. doi: 10.1038/s42003-020-0884-6. Full text in Research Archive
  • Gythfeldt, Hedda von der Lippe; Lien, Tonje Gulbrandsen; Tekpli, Xavier; Silwal-Pandit, Laxmi; Borgen, Elin & Garred, Øystein [Show all 15 contributors for this article] (2020). Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer. International Journal of Cancer. ISSN 0020-7136. 147(9), p. 2515–2525. doi: 10.1002/ijc.33108. Full text in Research Archive
  • Andersson, Yvonne; Inderberg, Else Marit ; Kvalheim, Gunnar; Herud, Morten Theodor Malmer; Engebråten, Olav & Flatmark, Kjersti [Show all 8 contributors for this article] (2019). Immune stimulatory effect of anti-EpCAM immunotoxin - improved overall survival of metastatic colorectal cancer patients. Acta Oncologica. ISSN 0284-186X. p. 1–7. doi: 10.1080/0284186X.2019.1704864.
  • Nome, Marianne Eikhom; Euceda, Leslie R.; Jabeen, Shakila; Debik, Julia; Bathen, Tone Frost & Giskeødegård, Guro F. [Show all 17 contributors for this article] (2019). Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers. International Journal of Cancer. ISSN 0020-7136. 146(1), p. 223–235. doi: 10.1002/ijc.32638. Full text in Research Archive
  • Debik, Julia Barbara; Euceda, Leslie R.; Lundgren, Steinar; Gythfeldt, Hedda; Garred, Øystein & Borgen, Elin [Show all 9 contributors for this article] (2019). Assessing treatment response and prognosis by serum and tissue metabolomics in breast cancer patients. Journal of Proteome Research. ISSN 1535-3893. 18(10), p. 3649–3660. doi: 10.1021/acs.jproteome.9b00316. Full text in Research Archive
  • Lindholm, Evita Maria; Aure, Miriam Ragle; Haugen, Mads Haugland; Sahlberg, Kristine Kleivi; Kristensen, Vessela N. & Nebdal, Daniel J.H. [Show all 9 contributors for this article] (2019). miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer. Molecular Oncology. ISSN 1574-7891. 13(10), p. 2278–2296. doi: 10.1002/1878-0261.12561. Full text in Research Archive
  • Lai, Xiaoran; Geier, Oliver; Fleischer, Thomas; Garred, Øystein; Borgen, Elin & Funke, Simon Wolfgang [Show all 14 contributors for this article] (2019). Towards personalized computer simulation of breast cancer treatment: a multi-scale pharmacokinetic and pharmacodynamic model informed by multi-type patient data. Cancer Research. ISSN 0008-5472. 79(16), p. 4293–4304. doi: 10.1158/0008-5472.CAN-18-1804. Full text in Research Archive
  • Møller, Elen Kristine; Nord, Silje; Wedge, David C; Lingjærde, Ole Christian; Silwal-Pandit, Laxmi & Gythfeldt, Hedda [Show all 19 contributors for this article] (2018). Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations. Genome Medicine. ISSN 1756-994X. 10:92. doi: 10.1186/s13073-018-0601-y. Full text in Research Archive
  • Fusser, Markus; Øverbye, Anders; Pandya, Abhilash D.; Mørch, Ýrr Asbjørg; Borgos, Sven Even F. & Kildal, Wanja [Show all 16 contributors for this article] (2018). Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft. Journal of Controlled Release. ISSN 0168-3659. 293, p. 183–192. doi: 10.1016/j.jconrel.2018.11.029. Full text in Research Archive
  • Bidard, François-Clément; Michiels, Stefan; Riethdorf, Sabine; Mueller, Volkmar; Esserman, Laura J. & Lucci, Anthony [Show all 50 contributors for this article] (2018). Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: A Meta-analysis. Journal of the National Cancer Institute. ISSN 0027-8874. 110(6), p. 560–567. doi: 10.1093/jnci/djy018.
  • Seip, Kotryna; Jørgensen, Kjetil; Haselager, Marco Vincent; Albrecht, Marco; Haugen, Mads Haugland & Egeland, Eivind Valen [Show all 11 contributors for this article] (2018). Stroma-induced phenotypic plasticity offers phenotype-specific targeting to improve melanoma treatment. Cancer Letters. ISSN 0304-3835. 439, p. 1–13. doi: 10.1016/j.canlet.2018.09.023. Full text in Research Archive
  • Jabeen, Shakila; Zucknick, Manuela; Nome, Marianne Eikhom; dannenfelser, ruth; Fleischer, Thomas & Kumar, Surendra [Show all 15 contributors for this article] (2018). Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab. Oncoimmunology. ISSN 2162-4011. 7(11), p. e1457598-1–e1457598-15. doi: 10.1080/2162402X.2018.1457598.
  • Prasmickaite, Lina; Tenstad, Ellen; Pettersen, Solveig; Jabeen, Shakila; Egeland, Eivind Valen & Nord, Silje [Show all 12 contributors for this article] (2018). Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4. Molecular Oncology. ISSN 1574-7891. 12(9), p. 1540–1558. doi: 10.1002/1878-0261.12319. Full text in Research Archive
  • Saldova, Radka; Haakensen, Vilde Drageset; Rødland, Einar Andreas; Walsh, Ian; Stöckmann, Henning & Engebråten, Olav [Show all 7 contributors for this article] (2017). Serum N-glycome alterations in breast cancer during multimodal treatment and follow-up. Molecular Oncology. ISSN 1574-7891. 11(10), p. 1361–1379. doi: 10.1002/1878-0261.12105.
  • Øverbye, Anders; Holsæter, Ann Mari; Fusser, Markus; Skalko-Basnet, Natasa; Iversen, Tore Geir & Torgersen, Maria Lyngaas [Show all 12 contributors for this article] (2017). Ceramide-containing liposomes with doxorubicin: time and cell-dependent effect of C6 and C12 ceramide. OncoTarget. ISSN 1949-2553. 8(44), p. 76921–76934. doi: 10.18632/oncotarget.20217. Full text in Research Archive
  • Silwal-Pandit, Laxmi; Nord, Silje; Gythfeldt, Hedda; Møller, Elen Kristine; Fleischer, Thomas & Rødland, Einar Andreas [Show all 25 contributors for this article] (2017). The longitudinal transcriptional response to neoadjuvant chemotherapy with and without bevacizumab in breast cancer. Clinical Cancer Research. ISSN 1078-0432. 23(16), p. 4662–4670. doi: 10.1158/1078-0432.CCR-17-0160. Full text in Research Archive
  • Euceda, Leslie R.; Haukaas, Tonje Husby; Giskeødegård, Guro F.; Vettukattil, Muhammad Riyas; Engel, Jasper & Silwal-Pandit, Laxmi [Show all 14 contributors for this article] (2017). Evaluation of metabolomic changes during neoadjuvant chemotherapy combined with bevacizumab in breast cancer using MR spectroscopy. Metabolomics. ISSN 1573-3882. 13:37, p. 1–14. doi: 10.1007/s11306-017-1168-0. Full text in Research Archive
  • Reinertsen, Kristin Valborg; Engebråten, Olav; Loge, Jon Håvard; Småstuen, Milada Cvancarova; Naume, Bjørn & Wist, Erik [Show all 10 contributors for this article] (2017). Fatigue During and After Breast Cancer Therapy—A Prospective Study. Journal of Pain and Symptom Management. ISSN 0885-3924. 53(3), p. 551–560. doi: 10.1016/j.jpainsymman.2016.09.011. Full text in Research Archive
  • Kristian, Alexandr; Holtedahl, Jon Erik; Torheim, Turid K Gjerstad; Futsæther, Cecilia Marie; Hernes, Eivor & Engebråten, Olav [Show all 8 contributors for this article] (2017). Dynamic 2-Deoxy-2-[<sup>18</sup>F]Fluoro-D-Glucose Positron Emission Tomography for Chemotherapy Response Monitoring of Breast Cancer Xenografts. Molecular Imaging and Biology. ISSN 1536-1632. 19(2), p. 271–279. doi: 10.1007/s11307-016-0998-x.
  • Sas-Chen, Aldema; Aure, Miriam Ragle; Leibovich, Limor; Carvalho, Silvia; Enuka, Yehoshua & Körner, Cindy [Show all 38 contributors for this article] (2016). LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer. EMBO Molecular Medicine. ISSN 1757-4676. 8(9), p. 1052–1064. doi: 10.15252/emmm.201606198. Full text in Research Archive
  • Easton, Douglas F; Lesueur, Fabienne; Decker, Brennan; Michailidou, Kyriaki; Li, Jun & Allen, Jamie [Show all 149 contributors for this article] (2016). No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: Implications for gene panel testing. Journal of Medical Genetics. ISSN 0022-2593. 53(5), p. 298–309. doi: 10.1136/jmedgenet-2015-103529.
  • Kim, Eugene; Tunset, Hanna Maja; Cebulla, Jana; Vettukattil, Muhammad Riyas; Helgesen, Heidi & Feuerherm, Astrid Jullumstrø [Show all 10 contributors for this article] (2016). Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model. BMC Cancer. ISSN 1471-2407. 16:191. doi: 10.1186/s12885-016-2225-1. Full text in Research Archive
  • Andersson, Yvonne; Engebråten, Olav; Juell, Siri; Aamdal, Steinar; Brunsvig, Paal Fr. & Fodstad, Øystein [Show all 7 contributors for this article] (2015). Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin. British Journal of Cancer. ISSN 0007-0920. 113(11), p. 1548–1555. doi: 10.1038/bjc.2015.380.
  • Pfister, Neil T.; Fomin, Vitalay; Regunath, Kausik; Zhou, Jeffrey Y.; Zhou, Wen & Silwal-Pandit, Laxmi [Show all 18 contributors for this article] (2015). Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells. Genes & Development. ISSN 0890-9369. 29(12), p. 1298–1315. doi: 10.1101/gad.263202.115.
  • Bagheri Fam, Shahla; Skjeldal, Frode Miltzow; Griffiths, Gareth Wyn; Mælandsmo, Gunhild; Engebråten, Olav & Nyström, Bo [Show all 8 contributors for this article] (2015). pH-Responsive Nano Carriers for Doxorubicin Delivery. Pharmaceutical Research. ISSN 0724-8741. 32(4), p. 1249–1263. doi: 10.1007/s11095-014-1530-0.
  • Esmaeili, Morteza; Moestue, Siver Andreas; Hamans, Bob C.; Veltien, Andor; Kristian, Alexandr & Engebråten, Olav [Show all 10 contributors for this article] (2015). In vivo 31P MRSI for metabolic profiling of human breast cancer xenografts. Journal of Magnetic Resonance Imaging. ISSN 1053-1807. 41(3), p. 601–609. doi: 10.1002/jmri.24588. Full text in Research Archive
  • Skrbo, Nirma; Hjortland, Geir Olav; Kristian, Alexandr; Holm, Ruth; Nordgard, Silje H. & Prasmickaite, Lina [Show all 10 contributors for this article] (2014). Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft. PLOS ONE. ISSN 1932-6203. 9(11). doi: 10.1371/journal.pone.0113278. Full text in Research Archive
  • Nilsen, Line; Fangberget, Anne; Geier, Oliver; Engebråten, Olav; Borgen, Elin & Olsen, Dag Rune [Show all 7 contributors for this article] (2014). Associations between tumor vascularization assessed by in vivo DCE-MRI and the presence of disseminated tumor cells in bone marrow in breast cancer patients at the time of diagnosis. Journal of Magnetic Resonance Imaging. ISSN 1053-1807. 40(6), p. 1382–1391. doi: 10.1002/jmri.24502.
  • Kristian, Alexandr; Riss, Patrick; Qu, Hong; Milde, Mona; Schoultz, Bent Wilhelm & Engebråten, Olav [Show all 8 contributors for this article] (2014). Positron emission tomography and pharmacokinetics of 2-[18F]-fluoroethyl choline for metabolic studies in breast cancer xenografts. Acta Oncologica. ISSN 0284-186X. 53(8), p. 1086–1092. doi: 10.3109/0284186X.2014.934398.
  • Lindholm, Evita Maria; Krohn, Marit; Iadevaia, Sergio; Kristian, Alexandr; Mills, Gordon B. & Mælandsmo, Gunhild [Show all 7 contributors for this article] (2014). Proteomic characterization of breast cancer xenografts identifies early and late bevacizumab-induced responses and predicts effective drug combinations. Clinical Cancer Research. ISSN 1078-0432. 20(2), p. 404–412. doi: 10.1158/1078-0432.CCR-13-1865.
  • Grinde, Maria Tunset; Skrbo, Nirma; Moestue, Siver Andreas; Rødland, Einar Andreas; Borgan, Eldrid & Kristian, Alexandr [Show all 13 contributors for this article] (2014). Interplay of choline metabolites and genes in patient-derived breast cancer xenografts. Breast Cancer Research. ISSN 1465-5411. 16(1). doi: 10.1186/bcr3597. Full text in Research Archive
  • Esmaeili, Morteza; Bathen, Tone Frost; Engebråten, Olav; Mælandsmo, Gunhild; Gribbestad, Ingrid S & Moestue, Siver Andreas (2014). Quantitative 31P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts. Magnetic Resonance in Medicine. ISSN 0740-3194. 71(6), p. 1973–1981. doi: 10.1002/mrm.24869. Full text in Research Archive
  • Moestue, Siver Andreas; Huuse, Else Marie; Lindholm, Evita Maria; Bofin, Anna M.; Engebråten, Olav & Mælandsmo, Gunhild [Show all 8 contributors for this article] (2013). Low-molecular contrast agent DCE-MRI and DW-MRI in early assessment of bevacizumab treatment in breast cancer xenografts. Journal of Magnetic Resonance Imaging. ISSN 1053-1807. 38(5), p. 1043–1053. doi: 10.1002/jmri.24079.
  • Borgan, Eldrid; Lindholm, Evita Maria; Moestue, Siver Andreas; Mælandsmo, Gunhild; Lingjærde, Ole Christian & Gribbestad, Ingrid S [Show all 9 contributors for this article] (2013). Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts. Molecular Oncology. ISSN 1574-7891. 7(1), p. 130–142. doi: 10.1016/j.molonc.2012.10.005. Full text in Research Archive
  • Moestue, Siver Andreas; Dam, Cornelia Gerarda; Gorad, Saurabh Sayajirao; Kristian, Alexandr; Bofin, Anna M. & Mælandsmo, Gunhild [Show all 9 contributors for this article] (2013). Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer. Breast Cancer Research. ISSN 1465-5411. 15(1).
  • Kristian, Alexandr; Nilsen, Line; Røe, Kathrine; Revheim, Mona Elisabeth; Engebråten, Olav & Mælandsmo, Gunhild [Show all 9 contributors for this article] (2013). Dynamic 18F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts. Nuclear medicine and molecular imaging. ISSN 1869-3474. 47, p. 173–180. doi: 10.1007/s13139-013-0211-y.
  • Kristian, Alexandr; Revheim, Mona Elisabeth; Qu, Hong; Mælandsmo, Gunhild; Engebråten, Olav & Seierstad, Therese [Show all 7 contributors for this article] (2013). Dynamic F-18-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts. Acta Oncologica. ISSN 0284-186X. 52(7), p. 1566–1572. doi: 10.3109/0284186X.2013.813634.
  • Engebråten, Olav; Vollan, Hans Kristian Moen & Børresen-Dale, Anne-Lise (2013). Triple-negative breast cancer and the need for new therapeutic targets. American Journal of Pathology. ISSN 0002-9440. 183(4), p. 1064–1074. doi: 10.1016/j.ajpath.2013.05.033.
  • Moestue, Siver Andreas; Dam, Cornelia Gerarda; Gorad, Saurabh Sayajirao; Kristian, Alexandr; Bofin, Anna M. & Mælandsmo, Gunhild [Show all 9 contributors for this article] (2013). Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer. Breast Cancer Research. ISSN 1465-5411. 15(1:R16). doi: 10.1186/bcr3391. Full text in Research Archive
  • Engesæter, Birgit Øvstebø; Engebråten, Olav; Flørenes, Vivi Ann & Mælandsmo, Gunhild (2012). Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma. PLOS ONE. ISSN 1932-6203. 7(9). doi: 10.1371/journal.pone.0045492. Full text in Research Archive
  • Lindholm, Evita Maria; Kristian, Alexandr; Nalwoga, Hawa; Kruger, Kristi; Nygård, Ståle & Akslen, Lars A. [Show all 8 contributors for this article] (2012). Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts. Molecular Oncology. ISSN 1574-7891. 6(4), p. 418–427. doi: 10.1016/j.molonc.2012.03.006. Full text in Research Archive
  • Huuse, Else Marie; Moestue, Siver Andreas; Lindholm, Evita Maria; Bathen, Tone Frost; Nalwoga, Hawa & Krüger, Kristi [Show all 11 contributors for this article] (2012). In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts. Journal of Magnetic Resonance Imaging. ISSN 1053-1807. 35(5), p. 1098–1107. doi: 10.1002/jmri.23507.
  • Engebråten, Olav; Edvardsen, Hege; Løkkevik, Erik; Naume, Bjørn; Kristensen, Vessela N. & Ottestad, Lars [Show all 7 contributors for this article] (2012). Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial. ISRN Oncology. ISSN 2090-5661. doi: 10.5402/2012/176789.
  • Grinde, Maria Tunset; Moestue, Siver Andreas; Borgan, Eldrid; Risa, Øystein; Engebråten, Olav & Gribbestad, Ingrid S (2011). 13C High-resolution-magic angle spinning MRS reveals differences in glucose metabolism between two breast cancer xenograft models with different gene expression patterns. NMR in Biomedicine. ISSN 0952-3480. 24(10), p. 1243–1252. doi: 10.1002/nbm.1683.
  • Engesæter, Birgit Øvstebø; Sathermugathevan, Menaka; Hellesnes, Tina; Engebråten, Olav; Holm, Ruth & Flørenes, Vivi Ann [Show all 7 contributors for this article] (2011). Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells. Cancer Biology & Therapy. ISSN 1538-4047. 12(1), p. 47–58. doi: 10.4161/cbt.12.1.15714.
  • Fangberget, Anne; Nilsen, Line; Hole, Knut Håkon; Holmen, Marit Muri; Engebråten, Olav & Naume, Bjørn [Show all 9 contributors for this article] (2011). Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. European Radiology. ISSN 0938-7994. 21(6), p. 1188–1199. doi: 10.1007/s00330-010-2020-3.
  • Moestue, Siver Andreas; Engebråten, Olav & Gribbestad, Ingrid S (2011). Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy. Molecular Oncology. ISSN 1574-7891. 5(3), p. 224–241. doi: 10.1016/j.molonc.2011.04.001. Full text in Research Archive
  • Moestue, Siver Andreas; Borgan, Eldrid; Huuse, Else Marie; Lindholm, Evita Maria; Sitter, Beathe & Børresen-Dale, Anne-Lise [Show all 9 contributors for this article] (2010). Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models. BMC Cancer. ISSN 1471-2407. 10. doi: 10.1186/1471-2407-10-433.

View all works in Cristin

  • Fusser, Markus; Øverbye, Anders; Pandya, Abhilash D.; Mørch, Ýrr Asbjørg; Borgos, Sven Even F. & Kildal, Wanja [Show all 16 contributors for this article] (2022). Corrigendum to “Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft”, [Journal of Control Release, 293 (2019) 183–192, (Journal of Control Release, (2019) 293(183-192) (S0168365918306928), (10.1016/j.jconrel.2018.11.029)). Journal of Controlled Release. ISSN 0168-3659. 349. doi: 10.1016/j.jconrel.2022.06.040.
  • Frigessi Di Rattalma, Arnoldo; Köhn-Luque, Alvaro; Kristensen, Vessela N.; Gørbitz, Carl Henrik & Engebråten, Olav (2020). Kan statistikk og matematikk redde like mange liv som nye medisiner? Aftenposten (morgenutg. : trykt utg.). ISSN 0804-3116.
  • Christoffersen, Thoralf; Helland, Åslaug; Engebråten, Olav; Straume, Oddbjørn & Guren, Tormod Kyrre (2016). Signalhemmere. In Dahl, Olav; Lehne, Gustav & Christoffersen, Thoralf (Ed.), Medikamentell kreftbehandling - Cytostatikaboken 8. utgave 2016. Universitetet i Oslo. ISSN 978-82-992331-4-9. p. 282–328.
  • Kim, Eugene; Kim, Jana; Feuerherm, Astrid Jullumstrø; Engebråten, Olav; Mælandsmo, Gunhild & Johansen, Berit [Show all 7 contributors for this article] (2016). Different anti-angiogenic drugs have different effects on the relationship between vascular structure and function in a patient-derived breast cancer model.
  • Skrbo, Nirma; Kirik, U.; Kristian, Alexandr; Cifani, P.; Antberg, L. & Moestue, Siver Andreas [Show all 11 contributors for this article] (2016). Protein expression analysis of intratumor heterogeneity in a luminal-like breast cancer xenograft.
  • Euceda, Leslie R.; Haukaas, Tonje Husby; Giskeødegård, Guro F.; Vettukattil, Muhammad Riyas; Postma, Geert & Engel, Jasper [Show all 10 contributors for this article] (2015). Evaluation of neoadjuvant chemotherapy in breast cancer using MR metabolomics.
  • Kim, Eugene; Feuerherm, Astrid Jullumstrø; Johansen, Berit; Engebråten, Olav; Mælandsmo, Gunhild & Bathen, Tone Frost [Show all 7 contributors for this article] (2015). cPLA2 Inhibition Affects the Relationship Between Vascular Function and Structure in a Patient-Derived Breast Cancer Model: A Correlation Study of DCE-MRI Vs. Micro-CT.
  • Euceda, Leslie R.; Haukaas, Tonje Husby; Giskeødegård, Guro F.; Vettukattil, Muhammad Riyas; Engel, Jasper & Postma, Geert [Show all 10 contributors for this article] (2015). Evaluation of neoadjuvant chemotherapy in breast cancer using MR metabolomics.
  • Kristian, Alexandr; Revheim, Mona Elisabeth; Qu, Hong; Mælandsmo, Gunhild; Engebråten, Olav & Malinen, Eirik (2014). Dynamic 18F-FDG PET parameters variation in patient-derived breast cancer xenograft and correlation with outcome following treatment with cytotoxic agents. Cancer Research. ISSN 0008-5472. 74. doi: 10.1158/1538-7445.AM2014-2053.
  • Kristian, Alexandr; Riss, Patrick; Qu, Hong; Milde, Mona; Schoultz, Bent Wilhelm & Engebråten, Olav [Show all 8 contributors for this article] (2014). Pharmacokinetic modeling of dynamic 18F‐Choline PET reflects choline metabolism in breast carcinoma xenografts.
  • Kristian, Alexandr; Revheim, Mona Elisabeth; Mælandsmo, Gunhild; Engebråten, Olav & Malinen, Eirik (2014). Variation in dynamic 18FFDG PET parameters in breast cancer PDX and correlation to treatment outcome. Radiotherapy and Oncology. ISSN 0167-8140. 111, p. 387–387.
  • Mathiesen, Randi R.; Borgen, Elin; Sætersdal, Anna Barbro; Fangberget, Anne; Schirmer, Cecilie & Stav, I [Show all 10 contributors for this article] (2013). Detection and monitoring of circulating endothelial cells, circulating tumor cells and disseminated tumor cells during neoadjuvant breast cancer treatment including bevacizumab.
  • Møller, Elen Kristine; Vollan, Hans Kristian Moen; Nord, Silje; von der Lippe Gythfeldt, H; Edvardsen, Hege & Silwal-Pandit, Laxmi [Show all 20 contributors for this article] (2013). A time course study of genomic instability in breast cancer patients receiving neoadjuvant chemotherapy with or without bevacizumab.
  • Engebråten, Olav; Vaske, Charles J.; Krohn, Marit; Silwal-Pandit, Laxmi; Vollan, Hans Kristian Moen & Møller, Elen Kristine [Show all 20 contributors for this article] (2013). Molecular response in breast cancer tumors treated with neoadjuvant chemotherapy with and without bevacizumab: Results from NeoAva - A randomized study.
  • Moestue, Siver Andreas; Grinde, Maria Tunset; Marangoni, Eilsabetta; Sørlie, Therese; Engebråten, Olav & Mælandsmo, Gunhild [Show all 8 contributors for this article] (2013). Cytosolic phospholipase A2 (cPLA2) as a therapeutic target in basal-like breast cancer.
  • Esmaeili, Morteza; Bathen, Tone Frost; Engebråten, Olav; Mælandsmo, Gunhild; Gribbestad, Ingrid S & Moestue, Siver Andreas (2013). Quantitative 31P Magnetic Resonance Spectroscopy Stratifies Treatment Response to a PI3K/mTOR Inhibitor in Two Distinct Breast Cancer Xenografts.
  • Esmaeili, Morteza; Bathen, Tone Frost; Engebråten, Olav; Mælandsmo, Gunhild; Gribbestad, Ingrid S & Moestue, Siver Andreas (2013). Quantitative 31P Magnetic Resonance Spectroscopy Stratifies Treatment Response to a PI3K/mTOR Inhibitor in Two Distinct Breast Cancer Xenografts.
  • Moestue, Siver Andreas; Grinde, Maria Tunset; Marangoni, Elisabetta; Skrbo, Nirma; Rødland, Einar Andreas & Borgan, Eldrid [Show all 14 contributors for this article] (2013). Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.
  • Moestue, Siver Andreas; Flatabø, Silje; Huuse, Else Marie; Lindholm, Evita Maria; Engebråten, Olav & Akslen, Lars A. [Show all 8 contributors for this article] (2012). Metabolic responses to VEGF inhibition in patient-derived breast cancer xenografts.
  • Moestue, Siver Andreas; Huuse, Else Marie; Lindholm, Evita Maria; Engebråten, Olav; Akslen, Lars A. & Mælandsmo, Gunhild [Show all 7 contributors for this article] (2011). DCE-MRI for early therapy monitoring of anti-angiogenic therapy.
  • Huuse, Else Marie; Moestue, Siver Andreas; Bathen, Tone Frost; Bofin, Anna M.; Mælandsmo, Gunhild & Akslen, Lars A. [Show all 8 contributors for this article] (2011). In vivo Dynamic Contrast Enhanced MRI & Histopathological Assessment of Tumor Angiogenesis in Luminal-like and Basal-like Breast Cancer Xenografts.
  • Moestue, Siver Andreas; Huuse, Else Marie; Lindholm, Evita Maria; Akslen, Lars A.; Engebråten, Olav & Mælandsmo, Gunhild [Show all 7 contributors for this article] (2011). Early vascular response to bevacizumab treatment measured by DCE-MRI in breast cancer xenografts.
  • Prasmickaite, Lina; Skrbo, Nirma; Høifødt, Hanne Kleppe; Suo, Zhenhe; Engebråten, Olav & Gullestad, Hans petter [Show all 9 contributors for this article] (2010). Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells. Pigment Cell & Melanoma Research. ISSN 1755-1471. 23(3), p. 449–451. doi: 10.1111/j.1755-148X.2010.00690.x.

View all works in Cristin

Published Apr. 13, 2011 2:54 PM - Last modified Nov. 5, 2015 1:34 PM